Detection of somatostatin receptor subtype 2 (SSTR2) in established tumors and tumor cell lines: Evidence for SSTR2 heterogeneity
- 1 January 1994
- Vol. 15 (7), 1229-1236
- https://doi.org/10.1016/0196-9781(94)90146-5
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Somatostatin receptor subtype gene expression in human and rodent tumorsLife Sciences, 1993
- Somatostatin-receptor imaging of human malignancies: A new era in the localization, staging, and treatment of tumorsGastroenterology, 1993
- Direct inhibitory effect of somatostatin on the growth of the human prostatic cancer cell line LNCaP: possible mechanism of actionJournal of Clinical Endocrinology & Metabolism, 1993
- Multiple Gene Transcripts of the Somatostatin Receptor SSTR2: Tissue-Selective Distribution and cAMP RegulationBiochemical and Biophysical Research Communications, 1993
- Molecular biology of somatostatin receptorsTrends in Neurosciences, 1993
- A cross-linking assay allows the detection of receptors for the somatostatin analogue, lanreotide in human breast tumoursEuropean Journal Of Cancer, 1993
- G Protein Activation of a Hormone-Stimulated Phosphatase in Human Tumor CellsScience, 1992
- Experimental and clinical studies with somatostatin analogue octreotide in small cell lung cancerBritish Journal of Cancer, 1991
- Growth of Human Breast Cancer Cell Lines Is Inhibited by the Somatostatin Analog BIM23014*Endocrinology, 1991
- Somatostatin inhibits the secretion of bombesin-like peptides from small cell lung cancer cellsPeptides, 1988